PROTEIN AND PEPTIDE LETTERS
Scope & Guideline
Pioneering pathways in therapeutic applications of proteins and peptides.
Introduction
Aims and Scopes
- Protein Structure and Function:
The journal publishes studies that explore the structural properties of proteins, their dynamics, and how these attributes relate to their biological functions. - Peptide Therapeutics and Drug Development:
Research on bioactive peptides, their mechanisms of action, and their potential applications in drug development and therapeutic interventions is a core focus. - Proteomics and Mass Spectrometry:
Innovative proteomic techniques, including mass spectrometry, are frequently featured, highlighting advancements in protein analysis and biomarker discovery. - Molecular Biology and Genetic Engineering:
The journal includes articles on the molecular mechanisms underlying gene expression, protein synthesis, and the use of genetic engineering techniques to modify proteins and peptides. - Biotechnology and Bioengineering Applications:
Studies that apply protein and peptide research to biotechnological processes, including enzyme engineering and the development of novel biomaterials, are emphasized. - Cancer Biology and Therapeutics:
There is a significant focus on the roles of proteins and peptides in cancer biology, including studies on oncogenic pathways and potential therapeutic targets. - Immunology and Vaccine Development:
Research related to the immunogenicity of proteins and peptides, including their use in vaccine development and immune response modulation, is also a key area of interest.
Trending and Emerging
- Protein-Protein Interactions and Networks:
There is a rising interest in studying protein-protein interactions and their implications in cellular networks, which is crucial for understanding complex biological processes. - Bioinformatics and Computational Biology:
The integration of bioinformatics tools to analyze protein structures, functions, and interactions is becoming more prevalent, facilitating deeper insights into protein science. - Peptide-Based Nanocarriers and Drug Delivery Systems:
Research on utilizing peptides as nanocarriers for drug delivery is on the rise, showcasing innovative approaches to enhance the bioavailability and efficacy of therapeutics. - Targeted Cancer Therapy:
A growing number of studies focus on the development of targeted therapies using engineered proteins and peptides, particularly in oncology, reflecting a shift towards personalized medicine. - Microbiome and Host Interactions:
Emerging research exploring the role of proteins and peptides in microbiome interactions and their effects on host health is gaining prominence, indicating a broader understanding of health and disease. - CRISPR and Gene Editing Technologies:
The applications of CRISPR and other gene-editing technologies in protein engineering and therapeutic development are increasingly being featured, highlighting their revolutionary impact on biotechnology.
Declining or Waning
- Traditional Enzymology:
Research focusing solely on classical enzymatic mechanisms without broader implications for protein engineering or therapeutic applications is waning, as interest shifts towards more applied and innovative approaches. - Basic Biochemical Pathways:
While foundational studies are essential, there is a noticeable decline in the publication of papers that exclusively describe basic metabolic pathways without integrating into larger biological or therapeutic contexts. - Agricultural Proteomics:
The application of proteomics specifically in agricultural settings, such as crop improvement, seems to be less emphasized in recent issues, indicating a shift towards more clinical and biomedical applications. - In Vitro Studies without Clinical Relevance:
Studies that focus solely on in vitro experiments without clear pathways to clinical application or relevance are becoming less common, as the journal seeks more translational research. - Historical Reviews on Protein Functions:
The journal appears to be moving away from historical reviews that do not incorporate current research trends or implications, favoring more forward-looking studies.
Similar Journals
CURRENT PROTEIN & PEPTIDE SCIENCE
Connecting Disciplines: Biochemistry, Cell Biology, and BeyondCURRENT PROTEIN & PEPTIDE SCIENCE, published by Bentham Science Publishers, is a pivotal journal dedicated to the dynamic and rapidly evolving fields of protein and peptide research. With an ISSN of 1389-2037 and an E-ISSN of 1875-5550, this esteemed journal serves as a platform for disseminating cutting-edge findings from various disciplines, including biochemistry, cell biology, and molecular biology. Recognized for its influence with a 2023 Scopus ranking placing it within the top quartiles of its categories—Q3 in Biochemistry, Q4 in Cell Biology, and Q2 in Medicine—the journal not only enhances the visibility of critical research but also supports the academic community in advancing our understanding of the molecular foundations of life. Established in 2000 and running through 2024, CURRENT PROTEIN & PEPTIDE SCIENCE is positioned to cater to the interests of researchers, professionals, and students alike, providing them with open access to vital knowledge that fuels innovation and scientific inquiry in the United Arab Emirates and beyond.
ACS Chemical Biology
Advancing the Frontiers of Chemical BiologyACS Chemical Biology is a premier journal published by the American Chemical Society, dedicated to advancing the understanding of the chemical underpinnings of biological systems. With an ISSN of 1554-8929 and a distinguished track record since its inception in 2006, this journal provides a vital platform for the dissemination of high-quality research in the realms of biochemistry and molecular medicine, achieving a prestigious Q1 ranking in these categories as of 2023. In an era where interdisciplinary approaches are crucial, ACS Chemical Biology fosters collaboration among chemists and biologists, reflecting a steadfast commitment to exploring the chemical processes that govern life. Although it does not operate under an open-access model, the journal maintains a rigorous peer-review process, ensuring the publication of influential studies that shape the future of chemical biology. With an increasing impact factor and a focus on innovative research, ACS Chemical Biology remains an authoritative resource for researchers, professionals, and students eager to engage with cutting-edge findings in this dynamic field.
Doklady Biochemistry and Biophysics
Exploring the Intersections of Life's Molecular MechanicsDoklady Biochemistry and Biophysics is a vital resource for the advancement of knowledge in the fields of biochemistry and biophysics, published by MAIK NAUKA/INTERPERIODICA/SPRINGER. Featuring an ISSN of 1607-6729 and an E-ISSN of 1608-3091, this journal plays a critical role in disseminating research findings and fostering scholarly discourse. Despite its recent ranking in the Q4 quartile for biochemistry and biophysics in 2023, it serves as an essential platform for researchers exploring these intertwined disciplines. The journal’s scope encompasses a wide variety of topics, enhancing the understanding of biochemical processes and physical principles in biological systems. With converged years of publication from 2001 to 2024, it stands as a continual source of knowledge for its readers, who include researchers, professionals, and students alike. While the journal currently does not offer open access options, its contributions remain significant within the scholarly community, illustrated by its competitive Scopus rankings across related fields.
MOLECULAR BIOLOGY
Pioneering Research in Molecular Biology Since 1971MOLECULAR BIOLOGY, published by PLEIADES PUBLISHING INC, serves as a vital repository for the dissemination of innovative research within the fields of biochemistry, genetics, and molecular biology. With an ISSN of 0026-8933 and an E-ISSN of 1608-3245, this journal has been a mainstay in the scientific community since its inception, embracing its deep historical roots from 1971 to the present. Recognized for its qualitative contributions, MOLECULAR BIOLOGY is ranked in the Q3 quartile for Biophysics and Q4 for Structural Biology, placing it among select journals in its domain. Researchers and students alike benefit from its rigorous peer-reviewed articles, which focus on all aspects of molecular mechanisms and interactions. The journal's inclusion in prestigious databases underlines its commitment to academic excellence. The editorial board is dedicated to fostering the sharing of influential findings, making it an essential resource for advancing knowledge and innovation in molecular biology.
PROTEIN EXPRESSION AND PURIFICATION
Elevating Standards in Protein MethodologiesPROTEIN EXPRESSION AND PURIFICATION, published by Academic Press Inc. Elsevier Science, is a premier journal in the field of biotechnology. With its ISSN 1046-5928 and E-ISSN 1096-0279, the journal has been a vital source of knowledge since its inception in 1990 and continues to provide high-quality research up to 2025. Though categorized in the third quartile (Q3) for 2023 within its scope of biochemistry, genetics, and molecular biology, it serves as a valuable platform for scientists and researchers focusing on the latest advancements in protein expression methodologies and purification techniques. The journal enjoys a respectable Scopus rank of 177 out of 311 in its category, representing a 43rd percentile position that underscores its impact in the research community. While not an Open Access journal, it offers a wealth of insights that can significantly enhance one's understanding of protein biochemistry, making it a must-read for professionals and students alike engaged in this dynamic field.
MOLECULAR & CELLULAR PROTEOMICS
Transforming proteomics with high-impact research.MOLECULAR & CELLULAR PROTEOMICS, published by Elsevier, stands as a premier journal in the fields of Biochemistry, Analytical Chemistry, and Molecular Biology, with a distinguished Q1 ranking reflecting its high impact and contribution to the scientific community. Established in 2002, this journal has consistently provided a platform for the latest research in protein science, merging molecular biology with advanced analytical techniques. With impressive Scopus rankings—41st in Biochemistry and 16th in Analytical Chemistry—it caters to an audience of researchers, professionals, and students eager to explore cutting-edge developments in proteomics. Although currently not designated as open access, the journal aims to foster knowledge dissemination through accessible research content. As it continues to evolve until 2024, MOLECULAR & CELLULAR PROTEOMICS is essential for anyone passionately engaged in the ever-expanding field of proteomics.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
Transforming Insights into Proteomic DiscoveriesBIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, published by Elsevier, is a prestigious academic journal that serves as a vital resource for researchers, professionals, and students in the fields of biochemistry, biophysics, and proteomics. With an ISSN of 1570-9639 and an E-ISSN of 1878-1454, this journal features high-impact research articles aimed at advancing our understanding of protein structure, function, and interactions, contributing significantly to both theoretical and applied sciences. Recognized for its quality, it proudly holds a Q1 ranking in Analytical Chemistry and Biophysics, and Q2 in Biochemistry for 2023, alongside notable Scopus rankings that reflect its influence in the realm of molecular biology. The journal's commitment to disseminating essential findings supports the ongoing evolution of proteomic sciences and encourages collaborative discourse among the global scientific community. For aspiring authors, the journal offers open access options, enabling broad visibility of their work. Join the conversation in this dynamic field and contribute to shaping the future of protein research!
Cell Chemical Biology
Catalyzing Discoveries in Biochemistry and Beyond.Cell Chemical Biology, published by Cell Press, stands at the forefront of interdisciplinary research in the realms of biochemistry, molecular biology, and pharmacology. With a robust impact factor evident in its prestigious Q1 quartile rankings across multiple categories including Clinical Biochemistry and Drug Discovery for 2023, this journal serves as a critical platform for disseminating cutting-edge scientific discoveries. As an Open Access publication, it ensures that vital research is accessible to a wide audience, fostering collaborations and driving innovation in the life sciences. Based in the United States, and featuring publications from 2016 to 2024, Cell Chemical Biology invites researchers, professionals, and students alike to contribute to its mission of advancing knowledge through rigorous peer-reviewed articles that address both fundamental and applied aspects of chemical biology.
Peptide Science
Connecting researchers through groundbreaking peptide discoveries.Peptide Science, published by Wiley, is an esteemed journal dedicated to advancing the understanding of peptide chemistry and its applications across various scientific disciplines, including biochemistry, biophysics, and organic chemistry. Since its inception in 2018 and continuing through 2024, this journal has provided an essential platform for the dissemination of innovative research, engaging articles, and critical reviews. With an impressive Q3 ranking in the fields of Biochemistry and Biomaterials, and a Q2 status in Biophysics and Organic Chemistry as of 2023, Peptide Science acknowledges its integral role in addressing significant scientific challenges. This open-access journal ensures that findings are readily available to a global audience, fostering collaboration and knowledge sharing among researchers, professionals, and students alike. The journal exemplifies excellence in scholarly communication, making it an essential resource for anyone interested in the intricate world of peptide research.
Proteomes
Unlocking the Secrets of Protein Structures and Functions.Proteomes, published by MDPI since 2013, is a notable open access journal that occupies a critical place in the realms of Biochemistry, Clinical Biochemistry, Molecular Biology, and Structural Biology. Based in Switzerland, this journal not only promotes the dissemination of high-quality research pertaining to protein structures and functions but also emphasizes interdisciplinary approaches that bridge various fields of biomedical science. With a Category Quartile ranking of Q2 across multiple pertinent categories in 2023, Proteomes boasts a competitive impact within the scientific community, evidenced by its robust Scopus rankings. Researchers, professionals, and students are invited to explore a wealth of pioneering studies and reviews that are made freely accessible, aligning with global trends in open scientific communication. Whether contributing original research or seeking to expand their knowledge, the journal serves as an invaluable resource for anyone engaged in the evolving landscape of proteomics.